Vutrisiran Market Growth and Strategic Outlook 2026-2033 The vutrisiran market is experiencing robust growth driven by increasing adoption in RNAi therapeutic applications and expanding indications. As novel therapeutic options for hereditary transthyretin-mediated amyloidosis (hATTR) gain traction, industry stakeholders are closely tracking evolving market size and trends. The analysis underscores significant market revenue growth alongside emerging market opportunities influenced by innovative drug delivery and patient-centric outcomes. Market Size and Overview The global vutrisiran market size is estimated to be valued at USD 1,425.4 million in 2026 and is expected to reach USD 5,797.6 million by 2033, exhibiting a compound annual growth rate (CAGR) of 22% from 2026 to 2033. Vutrisiran Market-https://www.coherentmi.com/industry-reports/vutrisiran-market